Mr Jonathan B Skidmore > Norton Rose Fulbright > Dallas, United States > Lawyer Profile
Norton Rose Fulbright Offices
2200 ROSS AVENUE
SUITE 3600
DALLAS, TX 75201-7932
TEXAS
United States
- Firm Profile
- Go to...
Mr Jonathan B Skidmore
Work Department
Life Sciences, Pharma and Healthcare Litigation
Career
https://nortonrosefulbright.com/en-us/people/1000782
Lawyer Rankings
United States > Healthcare > Life sciences
In addition to advising clients in the pharmaceuticals and medical devices clients, Norton Rose Fulbright also advises a number of retail pharmacies and drug distributors, supporting them in the event of data breaches and also providing data security compliance support, with New York-based David Kessler taking the lead on such matters. The practice also takes on a range of contentious work, including antitrust litigation and patent disputes before the ITC. D’Lesli Davis, a Dallas and New York-based litigator who represents clients facing mass tort and MDL cases, leads the group alongside Jonathan Skidmore, who handles disputes revolving around pharmaceutical and medical products and devices liability.
United States > Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
Led from Houston by Brett Young and also able to draw upon resources from other key offices including Dallas and Minneapolis, Norton Rose Fulbright has significant visibility among pharmaceutical manufacturers and medical device companies, including in major class actions and MDLs. In Dallas, D’Lesli Davis , who heads up the life sciences and healthcare sub-group, has vast industry knowledge and litigation smarts with which she uses to good effect on MDLs/class actions, as well as in relation to pharmacovigilance matters. As well as regularly representing clients on personal injury matters, Davis has also gained a strong reputation advising on economic loss issues, not only on behalf of affected consumers but also third party payers. Also based in Dallas, Jonathan B. Skidmore regularly forms a pivotal part of the team’s involvement in many of the highest-profile disputes in the sector and has gained particular acclaim for his trial record. Dallas-based senior associate Ellie Norris is also recommended and has experience defending pharmaceutical manufacturers against economic loss, consumer protection, and deceptive practices claims brought by individuals, third-party payers, and state governments.
Lawyer Rankings
- Product liability, mass tort and class action - defense: pharmaceuticals and medical devices United States > Dispute resolution
- Life sciences United States > Healthcare
Top Tier Firm Rankings
- Dispute resolution > International litigation
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Energy > Renewable/alternative power
Firm Rankings
- Transport > Aviation and air travel: finance
- Dispute resolution > E-discovery
- Industry focus > Education
- Energy > Energy litigation: oil and gas
- Energy > Energy transactions: oil and gas
- Dispute resolution > International litigation
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Finance > Project finance
- Finance > Restructuring (including bankruptcy): municipal
- Transport > Shipping: finance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Energy > Energy regulation: electric power
- Energy > Energy transactions: electric power
- Environment > Environment: litigation
- Dispute resolution > International arbitration
- Media, technology and telecoms > Outsourcing
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Finance > Structured finance: securitization
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Tax > US taxes: contentious
- Insurance > Advice to insurers
- Antitrust > Civil litigation/class actions: defense
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Labor and employment > Labor and employment disputes (including collective actions)
- Healthcare > Life sciences
- Intellectual property > Patents: litigation (full coverage)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Finance > Restructuring (including bankruptcy): corporate
- Healthcare > Service providers
- Tax > US taxes: non-contentious
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Dispute resolution > Corporate investigations and white-collar criminal defense